Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2996)
All Articles published online
|
Apr 14, 2009 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cury DB, Cury MS, Elias GVH, Mizsputen SJ. Infliximab to treat severe ulcerative colitis. World J Gastroenterol 2009; 15(14): 1771-1773 [PMID: 19360923 DOI: 10.3748/wjg.15.1771] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i14/1771.htm |
| Number | Citing Articles |
| 1 |
Heidi Waters, Julie Vanderpoel, Scott McKenzie, Orsolya Lunacsek, Meg Franklin, Barbara Lennert, John Goff, Damian H. Augustyn. Stability of infliximab dosing in inflammatory bowel disease: results from a multicenter US chart review. Journal of Medical Economics 2011; 14(4): 397 doi: 10.3111/13696998.2011.583152
|
| 2 |
Jing Feng, Yueying Chen, Qi Feng, Zhihua Ran, Jun Shen. Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural Network. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.678424
|
| 3 |
Ahmad Z. Al Meslamani. Understanding patient variability to biologic treatments in inflammatory bowel disease. Expert Opinion on Biological Therapy 2024; 24(5): 317 doi: 10.1080/14712598.2024.2359021
|
| 4 |
Ane Søgaard Teisner, Mark A Ainsworth, Jørn Brynskov. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: A Danish single center experience. Scandinavian Journal of Gastroenterology 2010; 45(12): 1457 doi: 10.3109/00365521.2010.510572
|
| 5 |
Qi Lv, Yao Xing, Yijun Liu, Qingzhu Chen, Jingyi Xu, Lihong Hu, Yinan Zhang. Didymin switches M1-like toward M2-like macrophage to ameliorate ulcerative colitis via fatty acid oxidation. Pharmacological Research 2021; 169: 105613 doi: 10.1016/j.phrs.2021.105613
|
| 6 |
Maryam Fareed Ashoor. Infliximab Induced Leukoencephalopathy and Peripheral Neuropathy: A Case Report and a Review of Literature. Journal of Neurology & Stroke 2018; 8(1) doi: 10.15406/jnsk.2018.08.00274
|
| 7 |
Laura Clua‐Ferré, Roger Suau, Irene Vañó‐Segarra, Iris Ginés, Carolina Serena, Josep Manyé. Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles: A focus on inflammatory bowel disease. Clinical and Translational Medicine 2024; 14(11) doi: 10.1002/ctm2.70075
|
| 8 |
De-Jun Cui. Early aggressive therapy for severe extensive ulcerative colitis. World Journal of Gastroenterology 2009; 15(33): 4218-4219 doi: 10.3748/wjg.15.4218
Abstract(732) |
Core Tip(583) |
Full Article(HTML)(1512)
|
Full Article (PDF)-507K(219)
|
Times Cited (0)
|
Total Visits (3158)
|
Open
|
| 9 |
Emily C. L. Wong, Shahin Merat, Cristina Monaco, Parambir S. Dulai, Vipul Jairath, John K. Marshall, Walter Reinisch, Neeraj Narula. Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study. Digestive Diseases and Sciences 2023; 68(6): 2635 doi: 10.1007/s10620-023-07956-8
|